cbdMD (YCBD) Acquisitions (2018 - 2019)

cbdMD's (YCBD) quarterly Acquisitions came in at -$250740.0 in Q3 2019, down 2271.74% quarter-over-quarter from -$10572.0 in Q2 2019.

cbdMD (YCBD) Acquisitions (2018 - 2019) Analysis & Trends

cbdMD has disclosed Acquisitions across 2 years of filings, most recently posting -$250740.0 for Q3 2019.

Acquisitions for Q3 2019 came in at -$250740.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was -$250740.0 (down 121.48% YoY), and the FY2019 annual result was $916555.0, changed N/A from the prior year.
Acquisitions came in at -$250740.0 for Q3 2019 at cbdMD, down from -$10572.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $1.2 million in Q4 2018 to a low of -$250740.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	2.09 Bn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	137.87 Mn
10	cbdMD	3,905.91	-3.38 Mn	3.00 Mn	-

Download Data